Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Low-dose oral minoxidil is an effective and safe treatment for hair loss.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Methotrexate plus prednisolone had the fewest serious side effects.

Ruxolitinib cream may help treat severe hair loss in children.

Ritlecitinib can help about 14,000 people with severe hair loss.

Upadacitinib improved multiple immune-related conditions in one patient.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.